Concepedia

Johnny Castillo Cabrera

JC

4

Publications

277

Citations

4

H-Index

2016

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

Novartis (United States)

Johnny Castillo Cabrera is an author at University of North Carolina at Chapel Hill specializing in medicine, pharmacology, and lung cancer.

ORCID

Top concepts

Publications per year

2016–2019

4

Publications

4

TBK1 Is a Synthetic Lethal Target in Cancer with <i>VHL</i> Loss

Lianxin Hu, Haibiao Xie, Xijuan Liu et al. · Cancer Discovery · 2019 · 101 citations · Full text

Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP Signaling

Hui Wang, Bo Lü, Johnny Castillo Cabrera et al. · Journal of Biological Chemistry · 2016 · 77 citations · Full text

, , +8

Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC

Hao Zeng, Johnny Castillo Cabrera, Mika Manser et al. · eLife · 2019 · 60 citations · Full text

TBK1 Limits mTORC1 by Promoting Phosphorylation of Raptor Ser877

Ricardo J. Antonia, Johnny Castillo Cabrera, Laura E. Herring et al. · Scientific Reports · 2019 · 39 citations · Full text

Rows per page

1–4 of 4